[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60140997D1 - Therapeutische zusammensetzungen zur pulmonalen verabreichung - Google Patents

Therapeutische zusammensetzungen zur pulmonalen verabreichung

Info

Publication number
DE60140997D1
DE60140997D1 DE60140997T DE60140997T DE60140997D1 DE 60140997 D1 DE60140997 D1 DE 60140997D1 DE 60140997 T DE60140997 T DE 60140997T DE 60140997 T DE60140997 T DE 60140997T DE 60140997 D1 DE60140997 D1 DE 60140997D1
Authority
DE
Germany
Prior art keywords
therapeutic compositions
pulmonary administration
therapeutic agent
microparticles
obtainable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140997T
Other languages
English (en)
Inventor
Glen P Martyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Quadrant Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Drug Delivery Ltd filed Critical Quadrant Drug Delivery Ltd
Application granted granted Critical
Publication of DE60140997D1 publication Critical patent/DE60140997D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE60140997T 2000-02-29 2001-02-27 Therapeutische zusammensetzungen zur pulmonalen verabreichung Expired - Lifetime DE60140997D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0004827.2A GB0004827D0 (en) 2000-02-29 2000-02-29 Compositions
PCT/GB2001/000834 WO2001064188A1 (en) 2000-02-29 2001-02-27 Therapeutic compositions for pulmonary delivery

Publications (1)

Publication Number Publication Date
DE60140997D1 true DE60140997D1 (de) 2010-02-25

Family

ID=9886657

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140997T Expired - Lifetime DE60140997D1 (de) 2000-02-29 2001-02-27 Therapeutische zusammensetzungen zur pulmonalen verabreichung

Country Status (11)

Country Link
US (2) US20030133879A1 (de)
EP (1) EP1259228B1 (de)
JP (1) JP2003525232A (de)
AT (1) ATE454136T1 (de)
AU (1) AU2001235783A1 (de)
CA (1) CA2401696A1 (de)
DE (1) DE60140997D1 (de)
ES (1) ES2339423T3 (de)
GB (1) GB0004827D0 (de)
PT (1) PT1259228E (de)
WO (1) WO2001064188A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011807D0 (en) * 2000-05-16 2000-07-05 Quadrant Holdings Cambridge Formulation for inhalation
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6749845B2 (en) * 2001-02-15 2004-06-15 Aeropharm Technology, Inc. Modulated release particles for lung delivery
US7229645B2 (en) 2001-06-08 2007-06-12 Powderject Research Limited Spray freeze-dried compositions
DE60227691D1 (de) 2001-11-01 2008-08-28 Nektar Therapeutics Sprühtrocknungsverfahren
CN1607941A (zh) * 2001-11-19 2005-04-20 贝克顿迪肯森公司 粒状药物组合物
GB0129489D0 (en) * 2001-12-10 2002-01-30 Quadrant Healthcare Uk Ltd Sustained-release compositions
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB2399084B (en) * 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
DE10339197A1 (de) * 2003-08-22 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
US7723712B2 (en) * 2006-03-17 2010-05-25 Micron Technology, Inc. Reduced power consumption phase change memory and methods for forming the same
CN103562229A (zh) * 2011-05-30 2014-02-05 诺维信生物制药丹麦公司 高分子量透明质酸的喷雾干燥
EP2938664A4 (de) * 2012-12-28 2016-08-24 Nathan T Starbard Poröse polymerpartikel und verfahren zur herstellung und verwendung davon
WO2015061618A1 (en) * 2013-10-23 2015-04-30 Jessup Donald W Hyaluronic acid formulation
CN109531857B (zh) * 2019-01-02 2020-11-06 华熙生物科技股份有限公司 一种透明质酸或其盐颗粒的制备方法及所得产品
WO2023224577A1 (en) * 2022-05-18 2023-11-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising micronized human insulin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0432232T3 (da) * 1989-05-01 1994-01-31 Alkermes Inc Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler
US5208998A (en) * 1991-02-25 1993-05-11 Oyler Jr James R Liquid substances freeze-drying systems and methods
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
KR100277622B1 (ko) * 1992-06-12 2001-01-15 이타가키 히로시 흡입용 초미립자 분말 및 그의 제조방법
AU4198793A (en) * 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
JPH08301762A (ja) * 1995-05-12 1996-11-19 Teijin Ltd 肺癌治療剤
US5922253A (en) * 1995-05-18 1999-07-13 Alkermes Controlled Therapeutics, Inc. Production scale method of forming microparticles
JP3007164B2 (ja) * 1995-07-12 2000-02-07 株式会社大貴 動物用排泄物処理材及びその製造方法
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
KR100236771B1 (ko) * 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
JP4266399B2 (ja) * 1997-12-04 2009-05-20 帝人株式会社 粉末状吸入用医薬品組成物
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
AU773556B2 (en) * 1999-04-05 2004-05-27 Mannkind Corporation Methods for fine powder formation
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles

Also Published As

Publication number Publication date
ES2339423T3 (es) 2010-05-20
PT1259228E (pt) 2010-04-07
EP1259228A1 (de) 2002-11-27
WO2001064188A1 (en) 2001-09-07
GB0004827D0 (en) 2000-04-19
JP2003525232A (ja) 2003-08-26
EP1259228B1 (de) 2010-01-06
CA2401696A1 (en) 2001-09-07
US20080112896A1 (en) 2008-05-15
AU2001235783A1 (en) 2001-09-12
ATE454136T1 (de) 2010-01-15
US20030133879A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
ATE454136T1 (de) Therapeutische zusammensetzungen zur pulmonalen verabreichung
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
DK1318788T3 (da) Nanopartikulær fastdosissammensætninger
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
DE60326859D1 (de) Arzneimittelverabreichung
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
WO2002015959A3 (en) Compounds and compositions for delivering active agents
WO2003066597A3 (en) Guanidino compounds
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AR053977A1 (es) Composiciones farmaceuticas con enmascaramiento de sabor
WO2003053413A3 (en) Sustained-release compositions
DK1330244T3 (da) Præparater der omfatter modafinilforbindelser
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
EE200300279A (et) Toimeaine parendatud vabanemisprofiiliga mikroosakesed ja nende valmistamise meetod
SE0001916D0 (sv) Novel formulation
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition